PULM
Pulmatrix, Inc.
Key Financials
Operating Income
$-5169000
↑ 47.1%
EPS (Diluted)
$-1.41
↑ 46.2%
Revenue
$7.8M
0.0%
Net Income
$-5162000
↑ 46.0%
Total Assets
$4.1M
↓ 58.4%
Shareholders' Equity
$3.8M
↓ 57.4%
Total Liabilities
$329000.00
↓ 67.0%
Cash & Equivalents
$4.1M
↓ 57.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 425 | 10/13/2026 | View on SEC |
| 424B3 | 10/7/2026 | View on SEC |
| DEFA14A | 10/7/2026 | View on SEC |
| ARS | 10/5/2026 | View on SEC |
| S-3/A | 10/5/2026 | View on SEC |
| EFFECT | 9/25/2026 | View on SEC |
| 424B3 | 9/25/2026 | View on SEC |
| DEFM14A | 9/25/2026 | View on SEC |
| S-4/A | 9/23/2026 | View on SEC |
| 425 | 9/22/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PULM |
| Company Name | Pulmatrix, Inc. |
| CIK | 1574235 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (888) 355-4440 |